There is significant morbidity and mortality associated with the presence of coronary
artery disease (CAD) in the setting of orthotopic liver transplantation in patients
with end-stage liver disease. The prevalence of CAD in this cohort is similar to,
if not higher, than the general population. Several studies show improved survival
rates for patients with obstructive CAD who undergo percutaneous coronary intervention
(PCI) and support a low threshold for PCI in these patients. However, a few studies
have failed to show improved mortality associated with PCI in this cohort. This review
hopes to highlight the current recommendations regarding the assessment of CAD in
patients with end-stage liver disease who are orthotopic liver transplantation candidates
and describe the outcomes of PCIs.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Influence of coronary artery disease on outcomes after liver transplantation.Transplant Proc. 2008; 40: 3554-3557
- Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation.Liver Transpl Surg. 1996; 2: 426-430
- The prevalence of coronary artery disease in liver transplant candidates over age 50.Transplantation. 1995; 59: 859-864
- Prevalence of coronary heart disease–United States, 2006-2010.MMWR Morb Mortal Wkly Rep. 2011; 60: 1377-1381
- The relationship between coronary artery disease and cardiovascular events early after liver transplantation.Liver Int. 2019; 39: 1363-1371
- The diagnostic and prognostic utility of risk factors defined by the AHA/ACCF on the evaluation of cardiac disease in liver transplantation candidates.BMC Cardiovasc Disord. 2019; 19: 102
- Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.Hepatology. 2014; 59: 1144-1165
- OPTN/SRTR 2016 annual data report: liver.Am J Transplant. 2018; 18: 172-253
- Anesthesia for liver transplant surgery.Anesthesiol Clin North America. 2004; 22: 687-711
- A prospective natural history study of coronary atherosclerosis following liver transplantation.Atherosclerosis. 2022; 344: 40-48
- Detection and treatment of coronary artery disease in liver transplant candidates.Liver Transpl. 2001; 7: 755-761
- Cardiac and pulmonary vascular risk stratification in liver transplantation.Clin Liver Dis. 2021; 25: 157-177
- Determinants of coronary artery disease in liver transplant candidates.Exp Clin Transplant. 2010; 8: 142-145
- Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.J Hepatol. 2008; 49: 595-599
- CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates.J Hepatol. 2021; 75: 142-149
- Preoperative evaluation of coronary artery disease in liver transplant candidates: many unanswered questions in clinical practice.Diagnostics (Basel). 2021; 11: 75
- Dobutamine stress echocardiography in patients undergoing orthotopic liver transplantation: a pooled analysis of accuracy, perioperative and long term cardiovascular prognosis.Int J Cardiovasc Imaging. 2013; 29: 1741-1748
- Dobutamine stress echocardiography, myocardial perfusion scintigraphy, invasive coronary angiography, and post-liver transplantation events: systematic review and meta-analysis.Clin Transplant. 2018; 32: e13222
- Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management.Liver Transpl. 2010; 16: 550-557
- Diagnostic accuracy of cardiac testing for coronary artery disease in potential liver transplant recipients: a systematic review and meta-analysis.Int J Cardiol Heart Vasc. 2021; 32100714
- Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation.Int J Cardiol. 2021; 339: 219-224
- Intraoperative management and early post-operative outcomes of patients with coronary artery disease who underwent orthotopic liver transplantation.Hepatobiliary Pancreat Dis Int. 2020; 19: 12-16
- The role of coronary calcium score in the risk assessment of liver transplant candidates.Transplant Proc. 2014; 46: 230-233
- Coronary computed tomography angiography in combination with coronary artery calcium scoring for the preoperative cardiac evaluation of liver transplant recipients.BioMed Res Int. 2017; 4081525
- Prognostic value of computed tomographic coronary angiography for long-term major adverse cardiac events after liver transplantation.J Clin Med. 2021; 10: 3132
- Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.Eur Radiol. 2021; 31: 494-503
- Coronary computer tomographic angiography for preoperative risk stratification in patients undergoing liver transplantation.Eur J Radiol. 2012; 81: 2260-2264
- Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation.Liver Transpl. 2011; 17: 809-813
- Quality and diagnostic performance of coronary computed tomography angiogram (CCTA): A comparison between pre-liver and pre-kidney transplant patients.Eur J Radiol. 2021; 143109886
Schuessler M, Saner F, Al-Rashid F, Schlosser T. Diagnostic accuracy of coronary computed tomography angiography-derived fractional flow reserve (CT-FFR) in patients before liver transplantation using CT-FFR machine learning algorithm [published online June 22, 2022]. Eur Radiol doi:10.1007/s00330-022-08921-1.
- Transradial cardiac catheterization in liver transplant candidates.Am J Cardiol. 2014; 113: 1634-1638
- Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: an evaluation of the evidence and consensus recommendations.Am J Transplant. 2018; 18: 30-42
- Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease.World J Cardiol. 2021; 13: 599-607
- Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting.Liver Transpl. 2004; 10: 1386-1390
- Combined off pump coronary artery bypass graft and liver transplant.Ann Card Anaesth. 2021; 24: 197-202
- Safety of transradial cardiac catheterization in patients with end-stage liver disease.Catheter Cardiovasc Interv. 2014; 83: 360-366
- Diagnostic yield of coronary angiography in asymptomatic orthotopic liver transplantation candidates.Cardiovasc Revasc Med. 2022; 35: 59-63
- Significance of coronary artery calcium found on non-electrocardiogram-gated computed tomography during preoperative evaluation for liver transplant.Am J Cardiol. 2019; 124: 278-284
- Outcome of liver transplant recipients with revascularized coronary artery disease: a comparative analysis with and without cardiovascular risk factors.Transplantation. 2017; 101: 793-803
- Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation.Liver Transpl. 2014; 20: 664-672
- Pre-liver transplant cardiac catheterization is associated with low rate of myocardial infarction and cardiac mortality.Hepatology. 2020; 72: 240-256
- Cardiac catheterization as a strategy for pre-operative risk stratification in patients undergoing liver transplantation.Circulation. 2008; 118 (S_903–S_904)
- Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization.Am J Cardiovasc Dis. 2014; 4: 133-139
- Cardiac catheterization in patients with end-stage liver disease: safety and outcomes.Catheter Cardiovasc Interv. 2011; 77: 45-48
- A comparison of arterial closure devices to manual compression in liver transplantation candidates undergoing coronary angiography.J Invasive Cardiol. 2003; 15: 68-70
- Risk of bleeding in end-stage liver disease patients undergoing cardiac catheterization.Tex Heart Inst J. 2015; 42: 414-418
- Primary results of the EVOLVE Short DAPT Study: evaluation of 3-month dual antiplatelet therapy in high bleeding risk patients treated with a bioabsorbable polymer-coated everolimus-eluting stent.Circ Cardiovasc Interv. 2021; 14e010144
- BASKET-SMALL 2 Investigators. Drug-coated balloon for small coronary artery disease in patients with and without high-bleeding risk in the BASKET-SMALL 2 trial.Circ Cardiovasc Interv. 2022; 15e011569
Article info
Publication history
Published online: October 11, 2022
Received in revised form:
August 30,
2022
Received:
July 2,
2022
Footnotes
Funding: None.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
